These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9272425)
1. Changes in prolactin levels with the menopause: the effects of estrogen/androgen and calcitonin treatment. Balint-Perić LA; Prelević GM Gynecol Endocrinol; 1997 Aug; 11(4):275-80. PubMed ID: 9272425 [TBL] [Abstract][Full Text] [Related]
2. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Reyes FI; Winter JS; Faiman C Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845 [TBL] [Abstract][Full Text] [Related]
3. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women. Robyn C; Vekemans M Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226 [TBL] [Abstract][Full Text] [Related]
4. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial. Moutos D; Smith S; Zacur H Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446 [TBL] [Abstract][Full Text] [Related]
5. [The acute feedback action of exogenously administered oestrogens on the serum-gonadotropin-levels in pre- and postmenopausal women (author's transl)]. Czygan PJ; Reich W Arch Gynakol; 1973 May; 215(1):17-38. PubMed ID: 4582609 [TBL] [Abstract][Full Text] [Related]
6. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Santoro N; Banwell T; Tortoriello D; Lieman H; Adel T; Skurnick J Am J Obstet Gynecol; 1998 Apr; 178(4):732-41. PubMed ID: 9579435 [TBL] [Abstract][Full Text] [Related]
7. Pituitary and ovarian function in women receiving hormonal contraception. Cohen BL; Katz M Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456 [TBL] [Abstract][Full Text] [Related]
8. Laboratory criteria for menopause in women using oral contraceptives. Creinin MD Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618 [TBL] [Abstract][Full Text] [Related]
9. The pituitary-gonadal axis in women with benign or malignant ovarian tumors. Blaakaer J; Djursing H; Hørding U; Bennett P; Toftager-Larsen K; Bock JE; Lebech PE Acta Endocrinol (Copenh); 1992 Aug; 127(2):127-30. PubMed ID: 1388313 [TBL] [Abstract][Full Text] [Related]
10. Different dopaminergic control of plasma luteinizing hormone, follicle-stimulating hormone and prolactin in ovulatory and postmenopausal women: effect of ovariectomy. De Leo V; Petraglia F; Bruno MG; Lanzetta D; Inaudi P; D'Antona N Gynecol Obstet Invest; 1989; 27(2):94-8. PubMed ID: 2499519 [TBL] [Abstract][Full Text] [Related]
11. Acute dopaminergic blockade augments the naloxone-induced LH rise in estrogen-treated postmenopausal women. Parra A; Barrón J; Marín VA; Coutiño B; Belmont J; Coria I Maturitas; 1997 May; 27(1):91-9. PubMed ID: 9158083 [TBL] [Abstract][Full Text] [Related]
12. Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women. Jeppsson S; Rannevik G; Thorell JI; Wide L Acta Endocrinol (Copenh); 1977 Apr; 84(4):713-28. PubMed ID: 322431 [TBL] [Abstract][Full Text] [Related]
13. Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal women. Faure N; Labrie F; Olivier G; Tremblay M; Cloutier D; Lemay A; Ferland L; Azadian-Boulanger G; Bouton MM; Husson JM; Raynaud JP Maturitas; 1980 Jul; 2(2):155-68. PubMed ID: 6782429 [TBL] [Abstract][Full Text] [Related]
14. Interactions of oestrogens and hours of sleep on cortisol, FSH, LH, and prolactin in hypogonadal women. Schiff I; Regestein Q; Schinfeld J; Ryan KJ Maturitas; 1980 Oct; 2(3):179-83. PubMed ID: 6777633 [TBL] [Abstract][Full Text] [Related]
15. Biphasic change in pituitary capacity induced by estrogen in hypogonadal women. Lachelin GC; Yen SS J Clin Endocrinol Metab; 1978 Mar; 46(3):369-73. PubMed ID: 109457 [TBL] [Abstract][Full Text] [Related]
16. Effects of long-lasting raloxifene treatment on serum prolactin and gonadotropin levels in postmenopausal women. Lasco A; Cannavò S; Gaudio A; Morabito N; Basile G; Nicita-Mauro V; Frisina N Eur J Endocrinol; 2002 Oct; 147(4):461-5. PubMed ID: 12370106 [TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947 [TBL] [Abstract][Full Text] [Related]
18. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix). Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507 [TBL] [Abstract][Full Text] [Related]
19. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma. Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809 [TBL] [Abstract][Full Text] [Related]
20. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause. Chakravarti S; Collins WP; Thom MH; Studd JW Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]